Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

When the Immune System Fails: Mechanisms of Immune Dysfunction

1Normal Immune Defense as a Layered System2Barrier and Innate Failure: When the First Lines Collapse3B-Cell and Antibody Failure4T-Cell and Thymic Failure5Regulatory Failure: Autoimmunity and Allergy
Regulatory Failure: Autoimmunity and Allergy

How Regulatory T Cells Hold the Line

2 / 4
The Treg mechanisms block lists four routes, and each one is worth connecting to what it removes. IL-2 consumption matters because conventional T cells depend on IL-2 as their main proliferation signal — the Treg acts as a sink. IL-10 and TGF-beta act on the dendritic cell and the effector cell, not just on one target. CTLA-4 is the contact-dependent route: by pulling CD80 and CD86 off the dendritic cell, the Treg prevents that dendritic cell from delivering signal 2 to any conventional T cell it later meets. The fourth route, adenosine and granzyme, is direct metabolic and cytolytic suppression. The point of the list is that suppression is redundant — losing one route is usually compensated, which is why Treg failure in humans typically reflects loss of the cells themselves, as in FOXP3 mutations, rather than loss of a single suppressive molecule.
0:00 / 0:00

Regulatory T cells are defined by FOXP3 and suppress through at least four distinct mechanisms; their loss removes restraint on self-reactive cells without reducing effector capacity, so the outcome is autoimmunity, not immunodeficiency.

Four suppression routes

  • IL-2 consumption: CD25 on Tregs strips IL-2 from the local environment, starving conventional T cells of their main growth signal.
  • Inhibitory cytokines: IL-10 and TGF-beta dampen dendritic cell maturation and effector T-cell activation.
  • Contact-dependent inhibition: CTLA-4 removes CD80 and CD86 from dendritic cells, cutting off costimulation to conventional T cells.
  • Metabolic and cytolytic suppression: adenosine generation and granzyme/perforin-mediated killing of target cells.

Because Tregs restrain rather than execute, their failure does not reduce the ability to fight infection. Effector T cells and B cells remain fully capable; what is lost is the brake. The clinical signature is therefore tissue-directed inflammation and autoantibody production, not opportunistic infection. This is the mechanistic distinction between regulatory failure and the effector failures covered in earlier chapters.

Previous2 / 4Next

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion